Converteo Launches an International AI and Agentic Systems Offering Dedicated to the Pharma & Life Sciences Industry
Rolled out across all markets where Converteo operates (France, Italy, Spain, the United States, and Canada), this new offering enables healthcare players to automate their complex workflows and deploy efficient and secure AI solutions and agents.
Converteo, a leading consulting firm specializing in data and artificial intelligence, today announces the launch of a service and solution offering for production-grade AI dedicated to the Pharma & Life Sciences sector.
Since 2024, the pharmaceutical sector has become one of the world's largest investors in AI.
In an environment shaped by increasing regulatory demands, cost pressures, and higher expectations for outcomes, Life Sciences companies need to accelerate innovation while building the agility, efficiency, and resilience required for long-term success.
